Ekso Bionics Holdings, Inc.
EKSO
$3.92
$0.082.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.06% | -1.94% | 4.12% | 15.63% | 23.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.06% | -1.94% | 4.12% | 15.63% | 23.82% |
| Cost of Revenue | -7.94% | -8.54% | -0.92% | 8.16% | 19.04% |
| Gross Profit | 3.72% | 4.76% | 9.28% | 23.56% | 28.91% |
| SG&A Expenses | -9.73% | -15.37% | -16.56% | -16.71% | -5.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.02% | -14.99% | -11.25% | -7.37% | 5.29% |
| Operating Income | 24.83% | 30.78% | 27.46% | 28.84% | 11.71% |
| Income Before Tax | 24.20% | 25.45% | 26.59% | 22.84% | 4.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.20% | 25.45% | 26.59% | 22.84% | 4.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.20% | 25.45% | 26.59% | 22.84% | 4.11% |
| EBIT | 24.83% | 30.78% | 27.46% | 28.84% | 11.71% |
| EBITDA | 27.36% | 34.01% | 31.14% | 33.71% | 16.79% |
| EPS Basic | 49.73% | 48.27% | 41.65% | 34.68% | 14.43% |
| Normalized Basic EPS | 50.12% | 48.83% | 42.20% | 35.20% | 14.98% |
| EPS Diluted | 49.92% | 48.45% | 41.32% | 34.37% | 14.09% |
| Normalized Diluted EPS | 50.12% | 48.83% | 42.20% | 35.20% | 14.98% |
| Average Basic Shares Outstanding | 48.66% | 45.34% | 29.97% | 20.69% | 13.67% |
| Average Diluted Shares Outstanding | 48.66% | 45.34% | 29.97% | 20.69% | 13.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |